Maravai Lifesciences Holdings, Inc.
MRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001823239
No open-market purchases or sales by Maravai Lifesciences Holdings, Inc. insiders were filed in the last 90 days; 177 institutions reported holding it in 13F filings for Q2 2026, worth $875.5M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Maravai Lifesciences Holdings, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 196
- +53 vs. Q1 2021
- Shares held
- 114.3M
- +17.4M (+18.0%) vs. Q1 2021
- Total value
- $4.77B
- +$1.32B (+38.1%) vs. Q1 2021
- New holders
- 80
- 74 more added
- Sold out
- 27
- 34 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 177 | $875.5M |
| Q1 2026 | 158 | $343.7M |
| Q4 2025 | 159 | $420.9M |
| Q3 2025 | 160 | $375.1M |
| Q2 2025 | 150 | $312.6M |
| Q1 2025 | 185 | $283.8M |
| Q4 2024 | 186 | $769.2M |
| Q3 2024 | 217 | $1.20B |
| Q2 2024 | 206 | $1.06B |
| Q1 2024 | 210 | $1.18B |
| Q4 2023 | 223 | $883.7M |
| Q3 2023 | 206 | $1.35B |
| Q2 2023 | 222 | $1.58B |
| Q1 2023 | 221 | $1.79B |
| Q4 2022 | 213 | $1.81B |
| Q3 2022 | 202 | $3.33B |
| Q2 2022 | 216 | $3.73B |
| Q1 2022 | 235 | $4.51B |
| Q4 2021 | 229 | $5.36B |
| Q3 2021 | 229 | $6.27B |
| Q2 2021 | 196 | $4.77B |
| Q1 2021 | 144 | $3.51B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Maravai Lifesciences Holdings, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Laurion Capital Management LP | 0 | $0 | 0.00% | −175,000−100.0% | Sold out |
| Anchorage Capital Group, L.L.C. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −123,764−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −58,168−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −57,600−100.0% | Sold out |
| Myriad Asset Management Ltd. | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −20,385−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −20,146−100.0% | Sold out |
| Azzad Asset Management Inc | 0 | $0 | 0.00% | −19,671−100.0% | Sold out |
| Pentwater Capital Management LP | 0 | $0 | 0.00% | −16,100−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −8,773−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −7,006−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −6,858−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −6,302−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −5,690−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −1,200−100.0% | Sold out |
| RMR Wealth Builders | 0 | $0 | 0.00% | −787−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −218−100.0% | Sold out |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Waddell & Reed Financial Inc | – | – | – | – | Not filed |